Evaluation of the induction of NS3 specific BVDV antibodies using a commercial inactivated BVDV vaccine in immunization and challenge trials
- 10 August 2007
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 25 (32), 6140-6145
- https://doi.org/10.1016/j.vaccine.2007.01.110
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responsesVaccine, 2005
- BVD control in Europe: current status and perspectivesAnimal Health Research Reviews, 2005
- Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABCVeterinary Microbiology, 2004
- Antibody responses of naive cattle to two inactivated bovine viral diarrhoea virus vaccines, measured by indirect and blocking ELISAs and virus neutralisationVeterinary Record, 2003
- An inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine affords clinical protection against BVDV type 2Vaccine, 2001
- Principles for eradication of bovine viral diarrhoea virus (BVDV) infections in cattle populationsVeterinary Microbiology, 1999
- A subunit vaccine based on glycoprotein E2 of bovine virus diarrhea virus induces fetal protection in sheep against homologous challengeVaccine, 1997
- A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccineVaccine, 1994
- Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's diseaseVeterinary Microbiology, 1990
- The application of monoclonal antibody panels to characterize pestivirus isolates from ruminants in Great BritainArchiv für die gesamte Virusforschung, 1988